(Q34327242)

1 August 2017

1 reference

title

Hormone replacement therapy for prevention of coronary heart disease: current evidence (English)

1 reference

Hormone Replacement Therapy

1 August 2017

main subject

1 reference

inferred from title

coronary artery disease

1 reference

Khurana PS

1

1 reference

1 August 2017

Khurana C

series ordinal

2

1 reference

1 August 2017

Hsia J

series ordinal

3

1 reference

1 August 2017

publication date

1 September 2001

1 reference

Current Atherosclerosis Reports

1 August 2017

published in

1 reference

1 August 2017

volume

3

1 reference

1 August 2017

issue

5

1 reference

1 August 2017

page(s)

399-403

1 reference

https://scigraph.springernature.com/pub.10.1007/s11883-001-0078-8

1 August 2017

exact match

0 references

cites work

The direct antiatherogenic effect of estrogen is present, absent, or reversed, depending on the state of the arterial endothelium. A time course study in cholesterol-clamped rabbits

1 reference

https://api.crossref.org/works/10.1007%2FS11883-001-0078-8

Menopause is associated with endothelial dysfunction in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-001-0078-8

Hormone therapy to prevent disease and prolong life in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-001-0078-8

Peripheral arterial disease in randomized trial of estrogen with progestin in women with coronary heart disease: the Heart and Estrogen/Progestin Replacement Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-001-0078-8

Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-001-0078-8

Plasma Homocysteine in Women Taking Hormone Replacement Therapy: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-001-0078-8

Divergent effects of hormone therapy on serum markers of inflammation in postmenopausal women with coronary artery disease on appropriate medical management

21 January 2018

1 reference

12 December 2020

Hormone replacement therapy, heart disease, and other considerations

1 reference

12 December 2020

Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group

1 reference

12 December 2020

Adherence to National Cholesterol Education Program Treatment goals in postmenopausal women with heart disease. The Heart and Estrogen/Progestin Replacement Study (HERS). The HERS Research Group

1 reference

12 December 2020

Estrogen-induced small low density lipoprotein particles may be atherogenic in postmenopausal women

1 reference

12 December 2020

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

1 reference

12 December 2020

Estrogen suppresses transcription of lipoprotein lipase gene. Existence of a unique estrogen response element on the lipoprotein lipase promoter

1 reference

12 December 2020

Clinical profiles of plain versus sustained-release niacin (Niaspan) and the physiologic rationale for nighttime dosing

1 reference

12 December 2020

The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women

1 reference

12 December 2020

Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men

1 reference

12 December 2020

Megatrials of hormonal replacement therapy.

1 reference

12 December 2020

Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence

1 reference

12 December 2020

Endothelial-dependent coronary vasomotor responsiveness in postmenopausal women with and without estrogen replacement therapy

1 reference

12 December 2020

Coronary heart disease in women, randomized clinical trials, HERS and RUTH

1 reference

12 December 2020

Effect of exogenous estrogen on atherothrombotic vascular disease risk related to the presence or absence of the factor V Leiden mutation (resistance to activated protein C).

1 reference

12 December 2020

AHA/ACC scientific statement: consensus panel statement. Guide to preventive cardiology for women. American Heart Association/American College of Cardiology

1 reference

12 December 2020

Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women

1 reference

12 December 2020

Effects of estrogens on macrophage foam cells: a potential target for the protective effects of estrogens on atherosclerosis.

1 reference

12 December 2020

Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial

1 reference

12 December 2020

Hormone replacement therapy, prothrombotic mutations, and the risk of incident nonfatal myocardial infarction in postmenopausal women

1 reference

12 December 2020

Estrogen increases eNOS and NOx release in human coronary artery endothelium

1 reference

12 December 2020

Effect of postmenopausal hormone therapy on lipoprotein(a) concentration. PEPI Investigators. Postmenopausal Estrogen/Progestin Interventions

1 reference

12 December 2020

Roles of endothelial dysfunction in coronary artery disease

1 reference

12 December 2020

A prospective investigation of elevated lipoprotein (a) detected by electrophoresis and cardiovascular disease in women. The Framingham Heart Study

1 reference

12 December 2020

Effects of estrogen replacement on the progression of coronary-artery atherosclerosis

1 reference

12 December 2020

Beyond the null hypothesis--do the HERS results disprove the estrogen/coronary heart disease hypothesis?

1 reference

12 December 2020

Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause

1 reference

12 December 2020

Postmenopausal hormone therapy and risk of stroke: The Heart and Estrogen-progestin Replacement Study (HERS)

1 reference

12 December 2020

Inflammation and thrombosis: the clot thickens

1 reference

12 December 2020

Effects of hormone-replacement therapy on hemostatic factors, lipid factors, and endothelial function in women undergoing surgical menopause: implications for prevention of atherosclerosis

1 reference

12 December 2020

Effect of menopause on plaque morphologic characteristics in coronary atherosclerosis

1 reference

12 December 2020

10.1007/S11883-001-0078-8

Identifiers

DOI

1 reference

Dimensions Publication ID

1 August 2017

1023997360

0 references

Fatcat ID

release_d26lrk4mzjfx7p3atz74vwrttq

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/d26lrk4mzjfx7p3atz74vwrttq

24 November 2022

mapped directly with Wikidata item

1 reference